Papers
34
Total Citations
637
H-Index
15
About
Kazunari Tanabe is a prominent urological surgeon and researcher whose work has fundamentally advanced the field of minimally invasive kidney surgery, particularly robot-assisted partial nephrectomy (RAPN) for renal cell carcinoma. His research consistently addresses critical clinical challenges, including reducing ischemic injury, preventing vascular complications such as renal artery pseudoaneurysm, and optimizing outcomes across diverse patient populations. Tanabe's most influential contributions include pioneering investigations into early unclamping techniques to mitigate pseudoaneurysm risk (68 citations) and identifying renal sinus exposure as an independent predictor of postoperative vascular complications (37 citations). His large-scale Japanese multicenter studies on "trifecta" outcomes — simultaneously achieving negative surgical margins, minimal complications, and preserved renal function — have established important benchmarks for RAPN quality assessment, garnering over 50 citations. Notably, his comparative analyses demonstrate RAPN's superiority over open surgery in reducing acute kidney injury and benefiting chronic kidney disease patients. Operating across prestigious multicenter collaborations involving up to 22 academic institutions, Tanabe has shaped evidence-based guidelines for complex scenarios including hilar tumors and elderly patients. His cumulative body of work, exceeding 400 citations, represents a significant contribution to refining surgical precision and improving patient safety in contemporary uro-oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10